These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

330 related articles for article (PubMed ID: 24604773)

  • 1. The efficacy and tolerability of commonly used agents to prevent recurrence of atrial fibrillation after successful cardioversion.
    Gonna H; Gallagher MM
    Am J Cardiovasc Drugs; 2014 Aug; 14(4):241-51. PubMed ID: 24604773
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oral amiodarone increases the efficacy of direct-current cardioversion in restoration of sinus rhythm in patients with chronic atrial fibrillation.
    Capucci A; Villani GQ; Aschieri D; Rosi A; Piepoli MF
    Eur Heart J; 2000 Jan; 21(1):66-73. PubMed ID: 10610746
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ibutilide in persistent atrial fibrillation refractory to conventional cardioversion methods.
    Naegeli B; Straumann E; Bertel O
    Int J Cardiol; 2005 Mar; 99(2):283-7. PubMed ID: 15749188
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Drug and electrical therapy of supraventricular tachyarrhythmias].
    Heisel A; Jung J; Schieffer H
    Z Kardiol; 2000; 89 Suppl 3():68-74. PubMed ID: 10810788
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optimal timing of electrical cardioversion in patients with persistent atrial fibrillation.
    Naji F; Vokac D; Kanic V; Sabovic M
    Med Sci Monit; 2010 Oct; 16(10):CR464-8. PubMed ID: 20885349
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Cardioversion of atrial fibrillation].
    Jóanesarson J; Riahi S; Hjortshøj S
    Ugeskr Laeger; 2013 Oct; 175(43):2549-53. PubMed ID: 24629150
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CHA2DS2-VASc in the prediction of early atrial fibrillation relapses after electrical or pharmacological cardioversion.
    Falsetti L; Viticchi G; Tarquinio N; Silvestrini M; Capeci W; Balloni A; Catozzo V; Gentile A; Pellegrini F
    J Cardiovasc Med (Hagerstown); 2014 Aug; 15(8):636-41. PubMed ID: 24978663
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Internal cardioversion in chronic atrial fibrillation].
    Mendoza González C; Iturralde Torres P; Guevara Valdivia ME; Nava Townsend S; Rodríguez Chávez L; Rodríguez Briones I
    Arch Cardiol Mex; 2002; 72(2):138-44. PubMed ID: 12148333
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Maintenance of sinus rhythm after electrical cardioversion of persistent atrial fibrillation; sotalol vs bisoprolol.
    Plewan A; Lehmann G; Ndrepepa G; Schreieck J; Alt EU; Schömig A; Schmitt C
    Eur Heart J; 2001 Aug; 22(16):1504-10. PubMed ID: 11482924
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Electrical cardioversion for persistent atrial fibrillation or atrial flutter in clinical practice: predictors of long-term outcome.
    Boriani G; Diemberger I; Biffi M; Domenichini G; Martignani C; Valzania C; Branzi A
    Int J Clin Pract; 2007 May; 61(5):748-56. PubMed ID: 17493088
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Contemporary approach to electrical and pharmacological cardioversion of atrial fibrillation.
    Rajagopalan B; Curtis AB
    Postgrad Med; 2012 Nov; 124(6):26-35. PubMed ID: 23322136
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardioversion of atrial fibrillation.
    Lip GY
    Postgrad Med J; 1995 Aug; 71(838):457-65. PubMed ID: 7567751
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardioversion of atrial fibrillation: the use of antiarrhythmic drugs.
    Schilling RJ
    Heart; 2010 Mar; 96(5):333-8. PubMed ID: 19910286
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Electrical and pharmacologic cardioversion for atrial fibrillation.
    Kim SS; Knight BP
    Med Clin North Am; 2008 Jan; 92(1):101-20, xi. PubMed ID: 18061000
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlation between inflammation state and successful medical cardioversion using bepridil for refractory atrial fibrillation.
    Nishino M; Mori N; Nakamura D; Lee Y; Yoshimura T; Taniike M; Makino N; Kato H; Egami Y; Shutta R; Tanouchi J; Yamada Y
    J Cardiol; 2013 Aug; 62(2):117-20. PubMed ID: 23623817
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The treatment of chronic atrial fibrillation].
    Gosselink AT
    Tijdschr Gerontol Geriatr; 1995 Dec; 26(6):259-63. PubMed ID: 8553436
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Short-term versus long-term antiarrhythmic drug treatment after cardioversion of atrial fibrillation (Flec-SL): a prospective, randomised, open-label, blinded endpoint assessment trial.
    Kirchhof P; Andresen D; Bosch R; Borggrefe M; Meinertz T; Parade U; Ravens U; Samol A; Steinbeck G; Treszl A; Wegscheider K; Breithardt G
    Lancet; 2012 Jul; 380(9838):238-46. PubMed ID: 22713626
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term efficacy and safety of very-low-dose amiodarone treatment for the maintenance of sinus rhythm in patients with chronic atrial fibrillation after successful direct-current cardioversion.
    Jong GP; Chang MH; Chang TC; Chou P; Fu CY; Tien LY; Chen CY; Ma TC
    Chin Med J (Engl); 2006 Dec; 119(24):2030-5. PubMed ID: 17199952
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of oral magnesium, alone or as an adjuvant to sotalol, after cardioversion in patients with persistent atrial fibrillation.
    Frick M; Darpö B; Ostergren J; Rosenqvist M
    Eur Heart J; 2000 Jul; 21(14):1177-85. PubMed ID: 10924301
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Facilitating internal cardioversion of chronic atrial fibrillation with ibutilide--predictors of atrial defibrillation-threshold decrease.
    Efremidis M; Sideris A; Batra R; Manolatos D; Xidonas S; Kardara D; Ekonomou D; Evagelou D; Filippatos G; Kardaras F
    Med Sci Monit; 2004 Jun; 10(6):CR258-63. PubMed ID: 15173670
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.